Home › Tests for new cancer drugs not reliable enough, doctors say
 

Keywords :   


Tests for new cancer drugs not reliable enough, doctors say

2015-06-02 08:56:21| Biotech - Topix.net

CHICAGO: Drugmakers including Bristol-Myers Squibb Co and Merck & Co are testing which patients will most benefit from new cancer treatments based on a protein found in their tumors, but that guide, known as a biomarker, may be too unreliable, researchers and health experts said. Bristol's Opdivo and Merck's Keytruda are both therapies designed to block a protein known as Programmed Death receptor that tumors use to evade the body's natural defenses.

Tags: say tests cancer reliable

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »